<code id='9C224C83EB'></code><style id='9C224C83EB'></style>
    • <acronym id='9C224C83EB'></acronym>
      <center id='9C224C83EB'><center id='9C224C83EB'><tfoot id='9C224C83EB'></tfoot></center><abbr id='9C224C83EB'><dir id='9C224C83EB'><tfoot id='9C224C83EB'></tfoot><noframes id='9C224C83EB'>

    • <optgroup id='9C224C83EB'><strike id='9C224C83EB'><sup id='9C224C83EB'></sup></strike><code id='9C224C83EB'></code></optgroup>
        1. <b id='9C224C83EB'><label id='9C224C83EB'><select id='9C224C83EB'><dt id='9C224C83EB'><span id='9C224C83EB'></span></dt></select></label></b><u id='9C224C83EB'></u>
          <i id='9C224C83EB'><strike id='9C224C83EB'><tt id='9C224C83EB'><pre id='9C224C83EB'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:56223
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis
          Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

          Microsoft'sheadofresearchPeterLeespeakingatSTATBreakthroughSummitinSanFrancisco.SarahGonzalezforSTAT

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Addiction experts warn against a second 'war on drugs'

          STAT'sLevFacher(left)spokewiththreeaddictionexperts—(fromleft)BraunzCourtney,KeithHumphreys,andAyesh